MAPT and Alzheimer disease: Alzheimer's disease (AD) is a progressive disorder characterized by cognitive decline, brain atrophy, and molecular pathology defined by the extracellular accumulation of misfolded amyloid-beta (Aβ) peptides, intracellular aggregation of hyperphosphorylated tau protein and neuroinflammation in the brain [1].